This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Jul;58(1):19-20.

doi: 10.1016/j.eururo.2010.02.025. Epub 2010 Mar 4.

Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development

Jack A Schalken

PMID: 20227175
DOI: 10.1016/j.eururo.2010.02.025

Editorial

Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development

Jack A Schalken. Eur Urol. 2010 Jul.

. 2010 Jul;58(1):19-20.

doi: 10.1016/j.eururo.2010.02.025. Epub 2010 Mar 4.

Author

Jack A Schalken

PMID: 20227175
DOI: 10.1016/j.eururo.2010.02.025

No abstract available

PubMed Disclaimer

Comment on

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.
Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, Lein M, Jung K. Jentzmik F, et al. Eur Urol. 2010 Jul;58(1):12-8; discussion 20-1. doi: 10.1016/j.eururo.2010.01.035. Epub 2010 Jan 26. Eur Urol. 2010. PMID: 20117878

Similar articles

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.
Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, Lein M, Jung K. Jentzmik F, et al. Eur Urol. 2010 Jul;58(1):12-8; discussion 20-1. doi: 10.1016/j.eururo.2010.01.035. Epub 2010 Jan 26. Eur Urol. 2010. PMID: 20117878
Beyond PSA: will future biomarker tests be better?
[No authors listed] [No authors listed] Mayo Clin Health Lett. 2009 Aug;27(8):4. Mayo Clin Health Lett. 2009. PMID: 19757525 No abstract available.
Biomarkers. Metabolite in urine may point to high-risk prostate cancer.
Couzin J. Couzin J. Science. 2009 Feb 13;323(5916):865. doi: 10.1126/science.323.5916.865a. Science. 2009. PMID: 19213886 No abstract available.
Urine markers in monitoring for prostate cancer.
Jamaspishvili T, Kral M, Khomeriki I, Student V, Kolar Z, Bouchal J. Jamaspishvili T, et al. Prostate Cancer Prostatic Dis. 2010 Mar;13(1):12-9. doi: 10.1038/pcan.2009.31. Epub 2009 Aug 4. Prostate Cancer Prostatic Dis. 2010. PMID: 19652665 Review.
Urinary markers for prostate cancer.
Downes MR, Byrne JC, Pennington SR, Dunn MJ, Fitzpatrick JM, Watson RW. Downes MR, et al. BJU Int. 2007 Feb;99(2):263-8. doi: 10.1111/j.1464-410X.2006.06610.x. Epub 2006 Dec 1. BJU Int. 2007. PMID: 17092277 Review.

See all similar articles

Cited by

Metabolomics: a novel approach to early and noninvasive prostate cancer detection.
Roberts MJ, Schirra HJ, Lavin MF, Gardiner RA. Roberts MJ, et al. Korean J Urol. 2011 Feb;52(2):79-89. doi: 10.4111/kju.2011.52.2.79. Epub 2011 Feb 19. Korean J Urol. 2011. PMID: 21379423 Free PMC article.
Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells.
Dahl M, Bouchelouche P, Kramer-Marek G, Capala J, Nordling J, Bouchelouche K. Dahl M, et al. Mol Biol Rep. 2011 Oct;38(7):4237-43. doi: 10.1007/s11033-010-0442-2. Epub 2011 Jul 14. Mol Biol Rep. 2011. PMID: 21755295 Free PMC article.
Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery.
Zhang T, Watson DG, Wang L, Abbas M, Murdoch L, Bashford L, Ahmad I, Lam NY, Ng AC, Leung HY. Zhang T, et al. PLoS One. 2013 Jun 18;8(6):e65880. doi: 10.1371/journal.pone.0065880. Print 2013. PLoS One. 2013. PMID: 23823321 Free PMC article.
Development of sarcosine quantification in urine based on enzyme-coupled colorimetric method for prostate cancer diagnosis.
Yamkamon V, Phakdee B, Yainoy S, Suksrichawalit T, Tatanandana T, Sangkum P, Eiamphungporn W. Yamkamon V, et al. EXCLI J. 2018 May 17;17:467-478. doi: 10.17179/excli2018-145. eCollection 2018. EXCLI J. 2018. PMID: 30034310 Free PMC article.
OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis.
Kraus VB, Blanco FJ, Englund M, Henrotin Y, Lohmander LS, Losina E, Önnerfjord P, Persiani S. Kraus VB, et al. Osteoarthritis Cartilage. 2015 May;23(5):686-97. doi: 10.1016/j.joca.2015.03.002. Osteoarthritis Cartilage. 2015. PMID: 25952342 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information